HeberFERON® in Patients With Basal Cell Carcinoma
Keywords:
basal cell carcinoma, HeberFERON®, satisfactory response.Abstract
Basal cell carcinoma is the most common non-melanoma neoplasm in fair-skinned individuals, accounting for 70% to 80% of skin cancer cases. There are several modalities for its treatment. Two patients with a history of hypertension and a diagnosis of basal cell carcinoma, located in the upper lip and left ankle, respectively, who were treated with HeberFERON® are presented. In both cases, the disappearance of the lesion was observed at the end of the sixth week of treatment. In both patients, adverse reactions were mild and transient. The importance of these cases lies in the advantage of having a domestically produced drug for the treatment of this type of neoplasm, when surgery cannot be performed. A satisfactory response and minimal adverse effects were achieved.
